Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of IV administration of
VX15/2503 in patients with multiple sclerosis. The escalation part of the study will
determine the maximum tolerated dose (MTD) or the Maximum Administered Dose if no MTD is
found.